Ricky Goldwasser analyst MORGAN STANLEY

Currently out of the existing stock ratings of Ricky Goldwasser, 139 are a HOLD (34.41%), 31 are a SELL (7.67%), 234 are a BUY (57.92%).

Ricky Goldwasser

Work Performance Price Targets & Ratings Chart

Analyst Ricky Goldwasser, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 71.6% that have a potential upside of 26.84% achieved within 322 days.

Ricky Goldwasser’s has documented 752 price targets and ratings displayed on 38 stocks. The coverage is on Healthcare, Consumer Defensive, Consumer Cyclical, Communication Services sectors.

Most recent stock forecast was given on ACCD, Accolade at 17-Dec-2024.

Wall Street Analyst Ricky Goldwasser

Analyst best performing recommendations are on OSH (OAK STREET HEALTH).
The best stock recommendation documented was for GDRX (GOODRX HOLDINGS) at 11/18/2020. The price target of $36 was fulfilled within 1 day with a profit of $2.24 (6.64%) receiving and performance score of 66.35.

Average potential price target upside

ABC AmerisourceBergen ACCD Accolade AMWL American Well Corp ANTM Anthem BHG Bright Health Group CAH Cardinal Health CERN Cerner Corp CI Cigna Corp CNC Centene Corp CRL Charles River Laboratories CVS CVS Health Corp DGX Quest Diagnostics DOCS Doximity GDRX Goodrx Holdings HUM Humana INOV Inovalon Holdings LH Laboratory of America Holdings MCK McKesson MOH Molina Healthcare NXGN Nextgen Healthcare ONEM 1Life Healthcare OSH Oak Street Health UNH UnitedHealth Group WBA Walgreens Boots Alliance LFST Lifestance Health Group ALHC Alignment Healthcare LLC CTLT Catalent DPLO Diplomat Pharmacy IQV IQVIA Holdings LVGO Livongo Health OSCR Oscar Health ELV Elevance Health ONE OneSmart International Education Group POSH Poshmark ATHN athenahealth OS OneStream WB Weibo Corp COR Cencora

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Feb-2018

$215

$40.04 (22.89%)

$187

3 years 2 months 17 days ago
(07-Aug-2023)

15/16 (93.75%)

$28.91 (15.54%)

636

Hold Since 27-May-2022

$190

$15.04 (8.60%)

$176

3 years 2 months 21 days ago
(03-Aug-2023)

12/12 (100%)

$-0.86 (-0.45%)

392

Buy Since 11-Oct-2022

$215

$40.04 (22.89%)

$200

3 years 2 months 21 days ago
(03-Aug-2023)

7/10 (70%)

$24.14 (12.65%)

211

Buy Since 05-Aug-2021

$220

$45.04 (25.74%)

$213

3 years 2 months 21 days ago
(03-Aug-2023)

11/17 (64.71%)

$29.14 (15.27%)

326

$190

$15.04 (8.60%)

3 years 2 months 21 days ago
(03-Aug-2023)

9/9 (100%)

$-0.86 (-0.45%)

440

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ricky Goldwasser?

On 2010
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?